The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura

International Journal of Hematology

Volumn 81, Issue 2, 2005, Pages 106-112

  Kuwana, Masataka ^a   Ikeda, Yasuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoreactive T cell; Cryptic epitope; GPIIb IIIa; Idiopathic thrombocytopenic purpura

Indexed keywords

CD4 ANTIGEN; CELL SURFACE RECEPTOR; EPITOPE; FIBRINOGEN; FIBRINOGEN RECEPTOR; LIGAND; THROMBOCYTE ANTIBODY;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; AUTOREACTIVE T CELL; B LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HYDROLYSIS; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IN VIVO STUDY; MACROPHAGE; PATHOGENESIS; PHAGOCYTOSIS; PROTEIN PROCESSING; RECEPTOR BINDING; REVIEW; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

AUTOIMMUNITY; EPITOPES, T-LYMPHOCYTE; HUMANS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; T-LYMPHOCYTES;

EID: 13944266299     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04176     Document Type: Review

References (55)

1. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346:995-1008.
2. McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol. 2000;37:239-248.
3. He R, Reid DM, Jones CE, Shulman NR. Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. Blood. 1994;83:1024-1032.
4. Hürlmann-Forster M, Steiner B, von Felten A. Quantitation of platelet-specific autoantibodies in platelet eluates of ITP patients measured by a novel ELISA using purified glycoprotein complexes GPIIb/IIIa and GPIb/IX as antigens. Br J Haematol. 1997;98:328-335.
5. Kuwana M, Okazaki Y, Kaburaki J, Ikeda Y. Detection of circulating B cells secreting platelet-specific autoantibody is a sensitive and specific test for the diagnosis of autoimmune thrombocytopenia. Am J Med. 2003;114:322-325.
6. Mohan C, Adams S, Stanik V, Datta SK. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993;177:1367-1381.
7. 2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site. Blood. 2001;98:1889-1896.
8. Fujisawa K, McMillan R. Platelet-associated antibody to glycoprotein Iib/IIIa from chronic immune thrombocytopenic purpura patients often binds to divalent cation-dependent antigens. Blood. 1993;81:1284-1289.
9. Kosugi S, Tomiyama Y, Honda S, et al. Platelet-associated anti-GPIIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura recognizing epitopes close to the ligand-binding site of glycoprotein (GP) IIb. Blood. 2001;98:1819-1827.
10. Kuwana M, Kaburaki J, Pandey JP, et al. HLA class II alleles in Japanese patients with immune thrombocytopenic purpura: associations with anti-platelet glycoprotein antibodies and responses to splenectomy. Tissue Antigens. 2000;56:337-343.
11. Roark JH, Bussel JB, Cines DB, Siegel DL. Genetic analysis of autoantibodies in idiopathic thrombocytopenic purpura reveals evidence of clonal expansion and somatic mutation. Blood. 2002;100:1388-1398.
12. Semple JW, Freedman J. Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood. 1991;78:2619-2625.
13. Ware RE, Howard TA. Phenotypic and clonal analysis of T lymphocytes in childhood immune thrombocytopenic purpura. Blood. 1993;82:2137-2142.
14. Filion MC, Bradley AJ, Devine DV, Decary F, Chartrand P. Autoreactive T cells in healthy individuals show tolerance in vitro with characteristics similar to but distinct from clonal anergy. Eur J Immunol. 1995;25:3123-3127.
15. Shimomura T, Fujimura K, Takafuta T, et al. Oligoclonal accumulation of T cells in peripheral blood from patients with idiopathic thrombocytopenic purpura. Br J Haematol. 1996;95:732-737.
16. Kuwana M, Kaburaki J, Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura: role in production of anti-platelet autoantibody. J Clin Invest. 1998;102:1393-1402.
17. Kuwana M, Medsger TA Jr, Wright TM. Highly restricted TCR-αβ usage by autoreactive human T cell clones specific for DNA topoisomerase I: recognition of an immunodominant epitope. J Immunol. 1997;158:485-491.
18. 2-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals. Arthritis Rheum. 2000;43:65-75.
19. Kuwana M, Okazaki Y, Kaburaki J, Kawakami Y, Ikeda Y. Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura. J Immunol. 2002;168:3675-3682.
20. Kuwana M, Kaburaki J, Kitasato H, et al. Immunodominant epitopes on glycoprotein IIb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Blood. 2001;98:130-139.
21. Semple JW. Pathogenic T-cell responses in patients with autoimmune thrombocytopenic purpura. J Pediatr Hematol Oncol. 2003;25(suppl 1):S11-S13.
22. Yamanouchi J, Hato T, Tamura T, Fujita S, Yasukawa M. Identification of an epitope on glycoprotein IIb-IIIa that is recognized by HLA-DRB1*0405- restricted CD4+'superior' T cells from a patient with immune thrombocytopenic purpura. J Thromb Haemost. 2004;2:348-350.
23. Semple JW, Milev Y, Cosgrave D, et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood. 1996;87:4245-4254.
24. Panitsas FP, Theodoropoulou M, Kouraklis A, et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood. 2004;103:2645-2647.
25. Kuwana M, Kawakami Y, Ikeda Y. Suppression of autoreactive T-cell response to glycoprotein IIb/IIIa by blockade of CD40/ CD154 interaction: implications for treatment of immune thrombocytopenic purpura. Blood. 2003;101:621-623.
26. Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-β1 (TGF-β1) in autoimmune diseases. J Autoimmun. 2000;14:23-42.
27. Andersson PO, Stockelberg D, Jacobsson S, Wadenvik H. A transforming growth factor-β1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Ann Hematol. 2000;79:507-513.
28. Mouzaki A, Theodoropoulou M, Gianakopoulos I, Vlaha V, Kyrtsonis MC, Maniatis A. Expression patterns of Th1 and Th2 cytokine genes in childhood idiopathic thrombocytopenic purpura (ITP) at presentation and their modulation by intravenous immunoglobulin G (IVIg) treatment: their role in prognosis. Blood. 2002;100:1774-1779.
29. Andersson PO, Olsson A, Wadenvik H. Reduced transforming growth factor-β1 production by mononuclear cells from patients with active chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2002;116:862-867.
30. Hermida G, Manjon R, Casanova F, Rodriguez-Salazar M. Oral vaccination with autologous platelets in chronic autoimmune thrombocytopenic purpura. Med Hypotheses. 2001;57:612-615.
31. Wybran J, Fudenberg HH. Cellular immunity to platelets in idiopathic thrombocytopenic purpura. Blood. 1972;40:856-861.
32. Olsson B, Andersson PO, Jernas M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9:1123-1124.
33. Gruel Y, Boizard B, Daffos F, Forestier F, Caen J, Wautier JL. Determination of platelet antigens and glycoproteins in the human fetus. Blood. 1986;68:488-492.
34. Filion MC, Proulx C, Bradley AJ, et al. Presence in peripheral blood of healthy individuals of autoreactive T cells to a membrane antigen present on bone marrow-derived cells. Blood. 1996;88:2144-2150.
35. Lo D, Freedman J, Hesse S, Brinster RL, Sherman L. Peripheral tolerance in transgenic mice: tolerance to class II MHC and non-MHC transgene antigens. Immunol Rev. 1991;122:87-102.
36. Snowden N, Reynolds I, Morgan K, Holt L. T cell responses to human type II collagen in patients with rheumatoid arthritis and healthy controls. Arthritis Rheum. 1997;40:1210-1218.
37. Kuwana M, Medsger TA Jr, Wright TM. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. J Clin Invest. 1995;96:586-596.
38. Kuwana M, Feghali CA, Medsger TA Jr, Wright TM. Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis. Arthritis Rheum. 2001;44:1654-1659.
39. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 1992;358:155-157.
40. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol. 1993;11:729-766.
41. Lanzavecchia A. How can cryptic epitopes trigger autoimmunity? J Exp Med. 1995;181:1945-1948.
42. Warnock MG, Goodacre JA. Cryptic T-cell epitopes and their role in the pathogenesis of autoimmune diseases. Br J Rheumatol. 1997;36:1144-1150.
43. 2-glycoprotein I: antiphospholipid syndrome and T-cell reactivity. Thromb Res. 2004;114:347-355.
44. Stasi R, Stipa E, Masi M, et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med. 1995;98:436-442.
45. Sandler SG. The spleen and splenectomy in chronic immune (idiopathic) thrombocytopenic purpura. Semin Hematol. 2000;37(suppl 1):10-12.
46. Stein HB, Patterson AC, Offer RC, Atkins CJ, Teufel A, Robinson HS. Adverse effects of D-penicillamine in rheumatoid arthritis. Ann Intern Med. 1980;92:24-29.
47. Garner SF, Campbell K, Metcalfe P, et al. Glycoprotein V: the predominant target antigen in gold-induced autoimmune thrombocytopenia. Blood. 2002;100:344-346.
48. Lazarus R, McDowell RS. Structural and functional aspects of RDG-containing protein antagonists of glycoprotein IIb-IIIa. Curr Opin Biotechnol. 1993;4:438-445.
49. Dong X, Hamilton KJ, Satoh M, Wang J, Reeves WH. Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen. J Exp Med. 1994;179:1243-1252.
50. 2- glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells. Blood. 2005. In press.
51. Mamula MJ, Fatenejad S, Craft J. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J Immunol. 1994;152:1453-1461.
52. Mamula MJ, Janeway CA Jr. Do B cells drive the diversification of immune responses? Immunol Today. 1993;14:151-152.
53. Bettaieb A, Oksenhendler E, Duedari N, Bierling P. Cross-reactive antibodies between HIV-gp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura. Clin Exp Immunol. 1996;103:19-23.
54. Franchini M, Veneri D. Helicobacter pylori infection and immune thrombocytopenic purpura: an update. Helicobacter. 2004;9:342-346.
55. Takahashi T, Yujiri T, Shinohara K, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2004;124:91-96.